期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管内皮生长因子评估肺癌支气管动脉灌注化疗栓塞术后近期疗效的价值 被引量：3

原文传递
导出
摘要 肺癌是一种具有很高发病率和病死率的常见肺部恶性肿瘤，是严重威胁人类健康和生命的疾病之一。近年来其发病率呈逐年上升和年轻化趋势，并且大部分患者确诊时已失去手术机会。对于无法手术的患者，支气管动脉灌注化疗（bronchial artery infusion，BAI）是治疗肺癌行之有效的方法之一。
作者 代文静 孙建 李云辉 蒋梦妮 叶茹燕 李万成
机构地区 成都医学院第一附属医院呼吸内科 成都医学院第一附属医院心血管内科 成都医学院第一附属医院影像系
出处 《中华肺部疾病杂志（电子版）》 CAS 2015年第1期61-62,共2页 Chinese Journal of Lung Diseases(Electronic Edition)
关键词 支气管肺癌 支气管动脉灌注化疗 血管内皮生长因子
分类号 R563 [医药卫生—呼吸系统]
  • 相关文献

参考文献9

  • 1Chaft JE, Rekhtman N, Sima CS, et al. Phase ]I study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers[J]. Cancer Chemother Pharmacol, 2013, 72 (4) : 931- 934.
  • 2Liu J, Liu C, Qiu L, et al. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth faetor-C and its association with lymphangiogenesis in primary human non-small cell lung eaneer[J]. Diagn Pathol, 2014, 9: 128.
  • 3Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline ( version 1. 1 ) [J]. Eur J Cancer, 2009, 45(2): 228-247.
  • 4Tammi S, Gotoh M, Kasai Y, et al. Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer [ J ]. J Cardiothorac Surg, 2013, 8: 175.
  • 5Yatabe Y. Recent changes in the therapeutic strategy for NSCLC in association with new anti-cancer agents[ J]. Rinsho Byori, 2013,61 (4) : 328-333.
  • 6周明,王远东,凌国辉,程国华,韩国栋,邹青峰,王建,谭小军,杨嵘皓,卢家玲.重组人血管内皮抑素与化疗联合治疗肺癌的时序性研究[J].中华实验外科杂志,2011,28(10):1743-1745. 被引量：11
  • 7张明川,梅同华,厉明,李长毅,盛伟利,李胜,谢华.持续小剂量化疗对A549肺癌生长及VE-Cadherin的影响[J].肿瘤防治研究,2011,38(6):624-627. 被引量：6
  • 8Jeong JH, Cho BC, Shim HS, et al. Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor[J]. J Korean Med Sci, 2013, 28(7): 1005-1014.
  • 9代文静,孙建,李云辉,蒋梦妮,叶茹燕,李万成.血管内皮生长因子评估肺癌支气管动脉灌注化疗栓塞术后近期疗效的价值[J].中华肺部疾病杂志（电子版）,2015,8(1):61-62. 被引量：3

二级参考文献35

  • 1王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量：625
  • 2杨林,王金万,孙燕,朱允中,刘晓晴,李维廉,邸立军,李佩文,王友良,宋恕平,姚晨,游丽芬.重组人血管内皮抑制素YH-16治疗晚期非小细胞肺癌的临床研究[J].中华肿瘤杂志,2006,28(2):138-141. 被引量：144
  • 3张明川,梅同华.抗肺癌血管生成治疗的进展[J].国际呼吸杂志,2006,26(6):467-470. 被引量：4
  • 4Bertolini F, Paul S, Mancuso P, et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothe- lial progenitor cells[J]. Cancer Res,2003, 63(15) :4342-4346.
  • 5Folkman J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med, 1971, 285(21): 1182-1186.
  • 6Zhao D, Jiang L, Hahn EW, et al. Continuous Low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology[J]. Neopla- sia, 2005,7(7) :678-687.
  • 7Emmenegger U, Man S, Shaked Y,et al. A Comparative anal- ysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens[J]. Cancer Res, 2004,64 ( 11 ) : 3994-4000.
  • 8Wallez Y, Vilgrain I, Huber P. Angiogenesis: The VE-ead- herin switch[J]. Trends Cardiovasc Med,2006,16(2) :55-59.
  • 9Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275 (5302) : 964-967.
  • 10Hunting CB, Noort WA, Zwaginga JJ,et al. Circulating endo- thelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization[J]. Vox Sang, 2005,88(1) : 1-9.

共引文献13

同被引文献33

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量：1518
  • 2孙燕.抗癌药急性及亚急性毒性反应分度标准(WHO标准).癌症,1992,11(3):24-24.
  • 3Chaft JE, Rekhtman N, Sima CS, et al. Phase ]I study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers[J]. Cancer Chemother Pharmacol, 2013, 72 (4) : 931- 934.
  • 4Liu J, Liu C, Qiu L, et al. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth faetor-C and its association with lymphangiogenesis in primary human non-small cell lung eaneer[J]. Diagn Pathol, 2014, 9: 128.
  • 5Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline ( version 1. 1 ) [J]. Eur J Cancer, 2009, 45(2): 228-247.
  • 6Tammi S, Gotoh M, Kasai Y, et al. Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer [ J ]. J Cardiothorac Surg, 2013, 8: 175.
  • 7Yatabe Y. Recent changes in the therapeutic strategy for NSCLC in association with new anti-cancer agents[ J]. Rinsho Byori, 2013,61 (4) : 328-333.
  • 8Jeong JH, Cho BC, Shim HS, et al. Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor[J]. J Korean Med Sci, 2013, 28(7): 1005-1014.
  • 9Chaft JE,Rekhtman N,Sima CS,et al.Phase D study of docetaxel and vinorel- bine as adjuvant chemotherapy for resected non-small cell lung cancers[J].Cancer Chemother Pharmacol,2013,72(4):931-934.
  • 10张明川,梅同华,厉明,李长毅,盛伟利,李胜,谢华.持续小剂量化疗对A549肺癌生长及VE-Cadherin的影响[J].肿瘤防治研究,2011,38(6):624-627. 被引量：6

引证文献3

二级引证文献8

中华肺部疾病杂志（电子版）
2015年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部